Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data to Pocket $12M in Private Stock Placement

NEW YORK, Nov. 18 (GenomeWeb News) - Clinical Data has signed agreements with investors for a $12-million private placement of its common stock, the company said today.


The investors will purchase 614,629 shares of newly issued common stock and receive warrants to purchase 307,315 shares of additional common stock, for a total price of $12.025 million.


The "certain institutional and other accredited investors" remain unnamed at this time.


Clinical Data said it will use the gross proceeds from the placement to pay down outstanding indebtedness and to support its growth plans as it integrates Genaissance's operations and Icoria.


The company expects to close the Icoria acquisition in mid-December.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.